Search

Immunocore Holdings PLC ADR

Open

32.33 -0.22

Overview

Share price change

24h

Current

Min

32.26

Max

32.96

Key metrics

By Trading Economics

Income

-14M

-786K

Sales

9.3M

116M

EPS

-0.02

Profit margin

-0.678

Employees

524

EBITDA

-13M

3.6M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+92.74% upside

Dividends

By Acuity

Next Earnings

5 Nov 2026

Market Stats

By TradingEconomics

Market Cap

211M

1.9B

Previous open

32.55

Previous close

32.33

Immunocore Holdings PLC ADR Chart

Past performance is not a reliable indicator of future results.

Related News

11 Sept 2026, 19:46 UTC

Immunocore Holdings PLC shares are lower amid continued declines, following the CPI data release that fueled interest rate hike speculation.

10 Sept 2026, 20:06 UTC

Immunocore Holdings PLC shares are declining, continuing a trend of lower performance amid cautious sentiment following the European Central Bank's interest rate hike.

8 Sept 2026, 19:26 UTC

Immunocore Holdings PLC is trading lower amid broader market concerns following a stronger-than-expected U.S. jobs report and speculation about interest rate hikes.

4 Sept 2026, 20:01 UTC

Immunocore Holdings PLC shares are lower today amid broader market declines and rising Treasury yields following strong labor market data. No specific company news was identified.

2 Sept 2026, 20:08 UTC

Immunocore Holdings PLC shares are higher as biotechnology stocks advance. This movement contrasts with the recent trend of higher daily closes since Tuesday.

1 Sept 2026, 20:09 UTC

Immunocore Holdings PLC is trading higher, recovering from an earlier dip despite broader market concerns over rising oil prices and potential Federal Reserve interest rate hikes.

31 Aug 2026, 21:01 UTC

Immunocore Holdings PLC shares are higher in after-market hours, despite recent market sentiment influenced by hawkish remarks from Fed Chair Kevin Warsh.

25 Aug 2026, 20:07 UTC

Immunocore Holdings PLC shares are higher amid positive market sentiment. The overall market benefits from declining oil prices and lower Treasury yields.

24 Aug 2026, 20:06 UTC

Immunocore Holdings PLC shares are lower amid rising oil prices and geopolitical tensions, including new U.S. sanctions against Iran. No specific company news was identified.

21 Aug 2026, 19:46 UTC

News

IMCR gains as JPMorgan reinstates coverage with Overweight rating.

20 Aug 2026, 20:02 UTC

Immunocore Holdings PLC shares are lower today, reflecting declines in the Biotechnology sub-sector. The stock has shown notable volatility during the session.

19 Aug 2026, 22:51 UTC

Immunocore Holdings PLC shares are higher in after-market hours, continuing an upward trend. No specific news was identified to explain the movement.

18 Aug 2026, 20:01 UTC

Immunocore Holdings PLC is rising amid biotechnology sector strength, despite pulling back from an earlier session high. No specific company news was identified.

17 Aug 2026, 19:23 UTC

News

Immunocore Holdings PLC shares are higher today following HC Wainwright's improved Q3 2026 earnings estimates, raising loss per share projections to -$0.08 from -$0.25.

14 Aug 2026, 22:16 UTC

Immunocore Holdings PLC shares are lower in after-market trading. Broader market sentiment is impacted by declining retail sales and consumer confidence.

11 Aug 2026, 20:01 UTC

Immunocore Holdings PLC is rising as biotechnology sector strength supports shares, though the stock has pulled back from an earlier session high.

10 Aug 2026, 19:16 UTC

News

Immunocore Holdings PLC reports second-quarter revenue of $115.93 million, with shares lower amid broader market trends and declining U.S. stock futures.

7 Aug 2026, 20:04 UTC

News

Immunocore Holdings reported a wider Q2 loss of 2 cents per share and $115.9 million in revenue, with shares trading lower since Thursday's close.

6 Aug 2026, 19:52 UTC

News

Immunocore Holdings PLC reported Q2 earnings of -$0.02 per share and revenue of $115.93 million, exceeding expectations. Shares are trading higher during Thursday's session.

5 Aug 2026, 20:02 UTC

Immunocore Holdings PLC is higher today, reflecting broader gains in the Biotechnology sector. No specific company news was identified to explain the movement.

4 Aug 2026, 19:51 UTC

Immunocore Holdings PLC shares are higher today amid broader market strength and a notable decline in crude oil prices, easing inflation concerns.

3 Aug 2026, 20:03 UTC

News

Immunocore Holdings PLC is declining in Monday's session, diverging from gains in major tech stocks and remaining below its 20-day moving average.

31 Jul 2026, 20:06 UTC

Immunocore Holdings PLC shares are lower today, with no specific news identified. The stock has fluctuated within a routine range during the session.

28 Jul 2026, 19:56 UTC

Immunocore Holdings PLC shares are lower today, continuing a three-session decline amid broader market sentiment influenced by declines in Asian markets.

27 Jul 2026, 18:06 UTC

Immunocore Holdings PLC shares are lower today, reflecting a broader market trend amid a significant decline in oil prices. No specific company news was identified.

24 Jul 2026, 15:26 UTC

Immunocore Holdings PLC shares are lower today, having declined from a session high. This movement occurs amid mixed labor market data and inflation concerns.

22 Jul 2026, 19:16 UTC

News

Immunocore Holdings PLC shares are higher as Wall Street Zen upgraded its rating to "buy," despite a mixed analyst outlook.

21 Jul 2026, 21:01 UTC

Immunocore Holdings PLC shares are higher in after-market trading, driven by optimistic sentiment in U.S. markets and better-than-expected results from major companies.

20 Jul 2026, 20:06 UTC

News

Immunocore Holdings PLC shares are lower amid broader market weakness. Analyst ratings show mixed sentiment, with upgrades and downgrades influencing performance.

Peer Comparison

Price change

Immunocore Holdings PLC ADR Forecast

Price Target

By TipRanks

92.74% upside

12 Months Forecast

Average 62.833 USD  92.74%

High 100 USD

Low 35 USD

Based on 6 Wall Street analysts offering 12 month price targets forImmunocore Holdings PLC ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

4

Buy

2

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Immunocore Holdings PLC ADR

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 2/3 clinical trial to treat advanced cutaneous melanoma. In addition, the company's product pipeline comprises IMC-F106C, which is in a Phase 3 clinical trial to treat first line advanced cutaneous melanoma; and in a Phase 1/2 clinical trial in multiple tumor types, such as platinum resistant ovarian, non-small cell lung, and endometrial carcinoma. Further, it develops IMC-R117C, which is in phase 1 clinical trial to treat colorectal and gastrointestinal cancers; IMC-M113V, which is in phase 1 clinical trial to treat human immunosuppression virus; IMC-I109V, which is in a Phase I clinical trial in patients with chronic hepatitis B virus; IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-P115C, which is in preclinical trial to treat multiple solid tumor cancers; and IMC-S118AI to treat type 1 diabetes and is in preclinical trial. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
help-icon Live chat